J. Sloan

M. Clark, J. Sloan, D. Midthun, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.

J. Sloan, R. Goldberg, A. Adjei, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.

J. Sloan, J. Sloan, R. Goldberg, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

The well-being of physicians.

T. Habermann, J. Sloan, T. Shanafelt, 2003, The American journal of medicine.

Burnout and Career Satisfaction Among Surgical Oncologists Compared with Other Surgical Specialties

H. Kuerer, J. Sloan, T. Shanafelt, 2010, Annals of Surgical Oncology.

Longitudinal Study Evaluating the Association Between Physician Burnout and Changes in Professional Work Effort.

S. Swensen, J. Sloan, T. Shanafelt, 2016, Mayo Clinic proceedings.

Palliative care consultations in patients with cancer: a mayo clinic 5-year review.

J. Sloan, E. Carey, T. Moynihan, 2011, Journal of oncology practice.

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling

R. Stupp, M. J. van den Bent, M. Weller, 2020, Neuro-oncology advances.

Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA

J. Sloan, RobertI Miller, M. Halyard, 2013, Supportive Care in Cancer.

Oncology fellows’ career plans, expectations, and well-being: do fellows know what they are getting into?

W. Gradishar, J. Sloan, T. Shanafelt, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

David D. Williams, J. Sloan, Arthur R. Williams, 2013, Cancer nursing.

Sex differences in fluorouracil-induced stomatitis.

J. Sloan, P. Novotny, J. Sloan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of a Scale to Measure Information Needs in Cancer Care

J. Sloan, L. Degner, B. Davison, 1998, Journal of Nursing Measurement.

QOL and Survival Comparisons by Race in Oncology Clinical Trials.

J. Buckner, J. Sloan, P. Novotny, 2016, Journal of cancer and clinical oncology.

Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer

M. Clark, T. Rummans, J. Sloan, 2013, International Psychogeriatrics.

The hospice patient's primary caregiver. What is their quality of life?

J. Sloan, P. Novotny, J. Kaur, 2003, Journal of psychosomatic research.

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors.

J. Sloan, M. Goetz, R. Goldberg, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin.

J. Sloan, R. Goldberg, A. Adjei, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.

S. Cha, D. Sargent, J. Sloan, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials.

J. Sloan, A. Grothey, J. Hubbard, 2015, Journal of the National Cancer Institute.

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.

E. Shaw, J. Sloan, A. Dueck, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.

J. Buckner, P. Brown, M. Clark, 2007, Journal of pain and symptom management.

Incremental costs of enrolling cancer patients in clinical trials: a population-based study.

S. Cha, C. Chute, J. Killian, 1999, Journal of the National Cancer Institute.

Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE).

A. Abernethy, L. Minasian, E. Basch, 2010 .

In Reply: Drs Patterson and Yealy raise questions about the psychometric properties of the assessments

J. Sloan, Peng-Hui Wang, 2010 .

Redesigning nighttime care for personal care residents.

J. Sloan, D. O'Rourke, K. Klaasen, 2001, Journal of gerontological nursing.

Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort.

M. Clark, C. Patten, J. Sloan, 2007, The oncologist.

Why do surgeons consider leaving practice?

J. Sloan, T. Shanafelt, C. Balch, 2011, Journal of the American College of Surgeons.

E. Trepman, J. Sloan, J. Huntington, 2008, Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons.

A Brief Patient-Reported Outcomes Quality of Life (PROQOL) Instrument to Improve Patient Care

C. Chute, J. Sloan, D. Eton, 2013, PLoS medicine.

A National Study of Medical Students’ Attitudes Toward Self-Prescribing and Responsibility to Report Impaired Colleagues

L. Dyrbye, J. Sloan, T. Shanafelt, 2015, Academic medicine : journal of the Association of American Medical Colleges.

Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis.

J. Jett, J. Sloan, P. Novotny, 2004, Mayo Clinic proceedings.

Cytokine Profile Changes In 309 Myelofibrosis Patients: Comparison Of JAK1/JAK2 Inhibitor Therapy Vs. Placebo – Correlative Analysis From The Comfort-I Trial

R. Dantzer, J. Sloan, C. Cleeland, 2013 .

Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.

Jeffrey L. Anderson, J. Sloan, W. Harmsen, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992)

J. Sloan, K. Burger, P. Atherton, 2016, Clinical trials.

Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993)

J. Sloan, C. Loprinzi, RobertI Miller, 2012, Supportive Care in Cancer.

Impact of organizational leadership on physician burnout and satisfaction.

S. Swensen, J. Sloan, T. Shanafelt, 2015, Mayo Clinic proceedings.

Meeting on the FDA draft guidance on patient-reported outcomes.

J. Sloan, A. Dueck, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Outcomes Assessment in Cancer: Statistical issues in the application of cancer outcome measures

J. Sloan, 2004 .

The prevalence of substance use disorders in American physicians.

J. Sloan, T. Shanafelt, C. West, 2015, The American journal on addictions.

The prevalence of substance use disorders in American physicians.

J. Sloan, T. Shanafelt, C. West, 2014, The American journal on addictions.

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma.

T. Habermann, J. Sloan, S. Ansell, 2002, Blood.

Phase I Study of Interleukin-12 in combination with Rituximab in patients with B-cell non-Hodgkin lymphoma

T. Habermann, J. Sloan, S. Ansell, 2001 .

Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia

J. Sloan, D. Loegering, J. Karp, 2005, Clinical Cancer Research.

Phase 1 Oncology Clinical Trials for Related Subpopulations: The Power Walk Design

S. Cha, J. Sloan, C. Erlichman, 2002 .

Relationship between genetic markers and quality of life (QOL) in stage III colon cancer (CC) patients (pts) prior to adjuvant treatment (N0147).

D. Sargent, J. Sloan, R. Diasio, 2012 .

Combining survival and toxicity effect sizes from clinical trials into an interpretable, quality-adjusted survival effect size estimate of treatment efficacy.

D. Sargent, J. Sloan, P. Novotny, 2014 .

Role of a Medical Social Worker in Improving Quality of Life for Patients with Advanced Cancer with a Structured Multidisciplinary Intervention

P. Brown, M. Clark, T. Rummans, 2007, Journal of psychosocial oncology.

PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

A. Abernethy, L. Minasian, E. Basch, 2010 .

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

S. Vincent Rajkumar, J. Sloan, D. Dingli, 2017, American journal of hematology.

Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice.

J. Buckner, J. Sloan, A. Grothey, 2014, Journal of oncology practice.

A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer

D. Sargent, J. Sloan, H. McLeod, 2005 .

Distress and Career Satisfaction Among 14 Surgical Specialties, Comparing Academic and Private Practice Settings

J. Freischlag, J. Sloan, T. Shanafelt, 2011, Annals of surgery.

J. Sloan, C. Loprinzi, E. Paskett, 2020, Cancer.

A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)

J. Sloan, C. Loprinzi, E. Paskett, 2020, Cancer.

An exploratory pilot study of palliative medicine compared to anesthesia-pain consultation for pain in patients with cancer.

J. Sloan, P. Novotny, R. H. Rho, 2011, The journal of supportive oncology.

Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in Patients with Advanced Malignancies with the Assessment of Pharmacokinetic and Pharmacodynamic End Points

J. Sloan, C. Erlichman, S. Kaufmann, 2005, Clinical Cancer Research.

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

R. Fonseca, J. Sloan, P. Anderson, 2005, Leukemia.

Asking the obvious questions regarding patient burden.

J. Sloan, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of patient-reported outcome assessment order

E. Basch, J. Sloan, P. Novotny, 2022, Clinical trials.

Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.

M. Taphoorn, J. Reijneveld, E. Basch, 2022, European journal of cancer.

Health and Quality of Life Outcomes Responsiveness and minimal important differences for patient reported outcomes

R. Hays, J. Sloan, D. Cella, 2006 .

Outcomes of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer Undergoing Chemotherapy

Pamela J. McCabe, J. Sloan, A. M. Dose, 2018, Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association.

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

J. Sloan, R. Goldberg, A. Adjei, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Complementary and Alternative Medicine Use among Long-Term Survivors: A Pilot Study

J. Cerhan, T. Habermann, M. Clark, 2011 .

The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer.

J. Sloan, C. Varricchio, 2002, Journal of the National Cancer Institute.

Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer

J. Sloan, A. Tan, M. Halyard, 2017, Quality of Life Research.

The medical marriage: a national survey of the spouses/partners of US physicians.

J. Sloan, T. Shanafelt, C. West, 2013, Mayo Clinic proceedings.

Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.

J. Sloan, A. Vincent, C. Loprinzi, 2006, Journal of the Society for Integrative Oncology.

The relationship between cigarette smoking and quality of life after lung cancer diagnosis.

J. Sloan, Ping Yang, J. Ebbert, 2004, Chest.

The Burden of Fatigue and Quality of Life in Myeloproliferative Disorders (MPDs): An International Internet Based Survey of 1179 MPD Patients.

J. Sloan, H. Kantarjian, S. Verstovsek, 2006 .

N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy.

D. Petereit, J. Sloan, C. Loprinzi, 2013, International journal of radiation oncology, biology, physics.

Perioperative Patient-Reported Outcomes Predict Serious Postoperative Complications: a Secondary Analysis of the COST Trial

J. Sloan, P. Novotny, H. Nelson, 2014, Journal of Gastrointestinal Surgery.

Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms.

Tara Symonds, Gordon H Guyatt, David Cella, 2002, Mayo Clinic proceedings.

Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank

J. Cerhan, J. Olson, J. Pathak, 2015, International journal of general medicine.

Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC)â€“An ACCRU Network study.

J. Sloan, M. Lacouture, A. Barzi, 2018 .

Reply to A. Chan et al

J. Sloan, C. Loprinzi, A. Grothey, 2011 .

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).

J. Sloan, R. Goldberg, A. Adjei, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Challenges in QOL assessment. Overview and introduction.

J. Sloan, 2005, Current problems in cancer.

Reply to M. Aapro et al

J. Sloan, C. Loprinzi, D. Steensma, 2011 .

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors.

J. Jett, J. Sloan, R. Goldberg, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.

J. Sloan, H. Kantarjian, S. Verstovsek, 2009, Leukemia research.

American ginseng (Panax quinquefolius) administration does not affect performance of the Roche COBAS Ampliprep/Taqman HIV-1 RNA assay

J. Sloan, B. Bauer, T. Brown, 2014, BMC Complementary and Alternative Medicine.

Feasibility of a Patient-Reported Outcomes Quality of Life Instrument to Improve Care in Underserved, Ethnic Minority Cancer Patients

J. Sloan, D. Northfelt, J. Griffin, 2019 .

Assessing health disparities in children using a modified housing-related socioeconomic status measure: a cross-sectional study

Sebastian M. Armasu, B. Yawn, J. Sloan, 2016, BMJ Open.

Marital Status and Quality of Life in Patients with Esophageal Cancer or Barrett's Esophagus: The Mayo Clinic Esophageal Adenocarcinoma and Barrett’s Esophagus Registry Study

J. Sloan, RobertI Miller, A. Jatoi, 2010, Digestive Diseases and Sciences.

Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

M. Bertagnolli, E. Basch, A. Bennett, 2020, Clinical trials.

Acupuncture for treatment of noncyclic breast pain: a pilot study.

J. Sloan, P. Novotny, B. Bauer, 2011, The American journal of Chinese medicine.

Improving attribution of adverse events in oncology clinical trials.

G. Y. Wong, L. Minasian, J. Sloan, 2019, Cancer Treatment Reviews.

Personal consequences of malpractice lawsuits on American surgeons.

J. Sloan, T. Shanafelt, C. Balch, 2011, Journal of the American College of Surgeons.

A Phase II Study of Topical Ceramides for Cutaneous Breast Cancer

J. Sloan, C. Loprinzi, S. Alberts, 2003, Breast Cancer Research and Treatment.

Pre-Emptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial.

J. Sloan, B. Pasche, M. Lacouture, 2021, The oncologist.

Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention.

J. Spertus, J. Sloan, V. Roger, 2012, The American journal of cardiology.

Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story

H. Choy, J. Sloan, J. Bradley, 2013 .

A pilot study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a phase I clinical trial.

E. Basch, J. Sloan, A. Dueck, 2013 .

Prostate cancer patients with Maspin-negative tumors can live over a decade §

J. Sloan, J. Quesenberry, A. Jatoi, 2004 .

Parental satisfaction of U.S. physicians: associated factors and comparison with the general U.S. working population

J. Sloan, T. Shanafelt, Omar Hasan, 2016, BMC medical education.

[Perception of symptom distress in lung cancer patients: I. Agreement between patients and their caregiving relatives].

J. Sloan, L. Degner, L. Kristjanson, 1999, Pflege.

The clinical significance of quality of life assessments in oncology: a summary for clinicians

G. Guyatt, J. Sloan, D. Cella, 2006, Supportive Care in Cancer.

Incorporating Validated Measures for Patient-reported Outcomes in Clinical Practice

J. Sloan, M. Halyard, J. Hubbard, 2014 .

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.

J. Sloan, R. Goldberg, S. Alberts, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA.

J. Sloan, RobertI Miller, M. Halyard, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392).

J. Buckner, J. Sloan, S. Mandrekar, 2012 .

Linking clinical significance to a sleep intervention model

J. Sloan, P. Novotny, M. Frost, 2003 .

Factors associated with resilience to and recovery from burnout: a prospective, multi‐institutional study of US medical students

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2010, Medical education.

Prevalence of alcohol use disorders among American surgeons.

J. Sloan, T. Shanafelt, C. Balch, 2012, Archives of surgery.

Special report: suicidal ideation among American surgeons.

T. Rummans, J. Sloan, T. Shanafelt, 2011, Archives of surgery.

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

J. Gribben, F. Cavalli, T. Habermann, 2018, The Lancet. Haematology.

Sample size and design considerations for phase II clinical trials with correlated observations.

D J Sargent, J A Sloan, S S Cha, 1997, Controlled clinical trials.

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Amy P Abernethy, Tito R Mendoza, Charles S Cleeland, 2015, JAMA oncology.

Quality of Life of Adults with Unhealed and Healed Diabetic Foot Ulcers

E. Trepman, J. Sloan, L. Guse, 2006, Foot & ankle international.

Intervention to promote physician well-being, job satisfaction, and professionalism: a randomized clinical trial.

L. Dyrbye, J. Sloan, T. Shanafelt, 2014, JAMA internal medicine.

Burnout and career satisfaction among US oncologists.

W. Gradishar, J. Sloan, T. Shanafelt, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Interactive Individualized Intervention to Promote Behavioral Change to Increase Personal Well-Being in US Surgeons

J. Sloan, T. Shanafelt, H. Nelson, 2014, Annals of surgery.

Intervention to Promote PhysicianWell-being , Job Satisfaction , and Professionalism A Randomized Clinical Trial

L. Dyrbye, J. Sloan, T. Shanafelt, 2014 .

A Multi-institutional Study Exploring the Impact of Positive Mental Health on Medical Students’ Professionalism in an Era of High Burnout

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2012, Academic medicine : journal of the Association of American Medical Colleges.

Avoiding Burnout: The Personal Health Habits and Wellness Practices of US Surgeons

J. Sloan, T. Shanafelt, C. Balch, 2012, Annals of surgery.

Surgeon distress as calibrated by hours worked and nights on call.

J. Freischlag, J. Sloan, T. Shanafelt, 2010, Journal of the American College of Surgeons.

Burnout and Career Satisfaction Among American Surgeons

J. Freischlag, J. Sloan, T. Shanafelt, 2009, Annals of surgery.

Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology

S. Singletary, H. Kuerer, J. Sloan, 2007, Annals of Surgical Oncology.

A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical students.

Matthew R. Thomas, L. Dyrbye, J. Sloan, 2006, Mayo Clinic proceedings.

Personal Life Events and Medical Student Burnout: A Multicenter Study

Matthew R. Thomas, L. Dyrbye, J. Sloan, 2006, Academic medicine : journal of the Association of American Medical Colleges.

Relationship between increased personal well-being and enhanced empathy among internal medicine residents

T. Habermann, J. Kolars, J. Sloan, 2005 .

Relationship between increased personal well-being and enhanced empathy among

T. Habermann, J. Kolars, J. Sloan, 2005, Journal of General Internal Medicine.

The Well-Being and Personal Wellness Promotion Strategies of Medical Oncologists in the North Central Cancer Treatment Group

J. Sloan, T. Shanafelt, P. Novotny, 2005, Oncology.

urgeon Distress as Calibrated by Hours Worked nd Nights on Call

J. Freischlag, J. Sloan, T. Shanafelt, 2022 .

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.

J. Sloan, C. Loprinzi, RobertI Miller, 2011, International journal of radiation oncology, biology, physics.

Distress and empathy do not drive changes in specialty preference among US medical students

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2012, Medical teacher.

Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.

J. Sloan, S. Mandrekar, A. Adjei, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

S. Cha, J. Sloan, D. Metzinger, 2003, Gynecologic oncology.

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Amy P Abernethy, Ram Chilukuri, Tito R Mendoza, 2014, Journal of the National Cancer Institute.

Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.

J. Sloan, P. Anderson, S. Markovic, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

The relation between cancer patient treatment decision‐making roles and quality of life

J. Sloan, J. Huntington, M. Huschka, 2013, Cancer.

Development and preliminary psychometric properties of a well-being index for medical students

L. Dyrbye, D. Szydlo, J. Sloan, 2010, BMC medical education.

The learning environment and medical student burnout: a multicentre study

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2009, Medical education.

Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers.

R. Colligan, M. Clark, T. Rummans, 2006, Mayo Clinic proceedings.

A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.

W. R. Bishop, J. Sloan, J. Sloan, 2000, Cancer research.

Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor.

J. Sloan, R. Goldberg, C. Erlichman, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Michael Koller, Corneel Coens, Andrew Bottomley, 2020, The Lancet. Oncology.

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

L. Hartmann, J. Sloan, J. Sloan, 2010, Cancer research.

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

L. Collette, M. Piccart, M. Taphoorn, 2016, The Lancet. Oncology.

Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.

David Cella, Stephen Joel Coons, Ron D Hays, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia.

Deborah A. Bowen, J. Sloan, T. Shanafelt, 2009, Leukemia research.

Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients

Deborah A. Bowen, J. Sloan, T. Shanafelt, 2007, British journal of haematology.

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.

Afsaneh Barzi, Katrina Pedersen, Jeannine S McCune, 2019, The Lancet. Oncology.

Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy

S. Cha, J. Sloan, D. Metzinger, 2003 .

Suicidal Ideation Among American Surgeons

T. Rummans, J. Sloan, T. Shanafelt, 2017 .

The Impact of Stigma and Personal Experiences on the Help-Seeking Behaviors of Medical Students With Burnout

L. Dyrbye, S. Durning, C. Moutier, 2015, Academic medicine : journal of the Association of American Medical Colleges.

Satisfaction with work-life balance and the career and retirement plans of US oncologists.

W. Gradishar, J. Sloan, T. Shanafelt, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ability of the physician well-being index to identify residents in distress.

L. Dyrbye, J. Sloan, T. Shanafelt, 2014, Journal of graduate medical education.

A Survey of U.S. Physicians and Their Partners Regarding the Impact of Work–Home Conflict

L. Dyrbye, J. Sloan, T. Shanafelt, 2013, Journal of General Internal Medicine.

Utility of a Brief Screening Tool to Identify Physicians in Distress

L. Dyrbye, J. Sloan, T. Shanafelt, 2013, Journal of General Internal Medicine.

Efficacy of a Brief Screening Tool to Identify Medical Students in Distress

L. Dyrbye, D. Szydlo, J. Sloan, 2011, Academic medicine : journal of the Association of American Medical Colleges.

Relationship between work-home conflicts and burnout among American surgeons: a comparison by sex.

J. Freischlag, L. Dyrbye, J. Sloan, 2011, Archives of surgery.

Burnout and Serious Thoughts of Dropping Out of Medical School: A Multi-Institutional Study

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2010, Academic medicine : journal of the Association of American Medical Colleges.

Burnout and Suicidal Ideation among U.S. Medical Students

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2008, Annals of Internal Medicine.

Relationship between burnout and professional conduct and attitudes among US medical students.

Steven J Durning, William V. Harper, Matthew R. Thomas, 2010, JAMA.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

W. Curran, H. Choy, J. Sloan, 2016, JAMA oncology.

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity.

J. Sloan, R. Goldberg, S. Alberts, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of individual-level versus area-level socioeconomic measures in assessing health outcomes of children in Olmsted County, Minnesota

B. Yawn, J. Sloan, T. Beebe, 2013, Journal of Epidemiology & Community Health.

Patients with reconstruction of craniofacial or intraoral defects: development of instruments to measure quality of life.

J. Sloan, P. Novotny, A. Sugar, 2001, The International journal of oral & maxillofacial implants.

Relationship of Pass/Fail Grading and Curriculum Structure With Well-Being Among Preclinical Medical Students: A Multi-Institutional Study

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2011, Academic medicine : journal of the Association of American Medical Colleges.

Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors

M. Clark, C. Patten, J. Sloan, 2010, Cancer.

Lessons From Large-Scale Collection of Patient-Reported Outcomes: Implications for Big Data Aggregation and Analytics.

J. Sloan, I. El Naqa, C. Mayo, 2016, International journal of radiation oncology, biology, physics.

Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas

R. Arusell, J. Buckner, P. Brown, 2006, Journal of Neuro-Oncology.

Challenges With Health‐related Quality of Life Assessment in Arthroplasty Patients: Problems and Solutions

J. Singh, J. Sloan, N. Johanson, 2010, The Journal of the American Academy of Orthopaedic Surgeons.

Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer.

J. Sloan, L. Degner, Lesley F. Degner, 1995, Journal of pain and symptom management.

Patient-Reported Outcomes after Laparoscopic Ventral Hernia Repair

J. Sloan, K. Ballman, J. Bingener, 2016, The American surgeon.

Information needs and decisional preferences in women with breast cancer.

K C Carriere, J A Sloan, K. Carriere, 1997, JAMA.

Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.

L. Collette, M. Piccart, J. Reijneveld, 2018, The Lancet. Oncology.

A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival

R. Arusell, J. Buckner, P. Brown, 2005, Neurosurgery.

Cancer Caregiver: Perceived Benefits of Technology.

M. Clark, T. Rummans, J. Sloan, 2015, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Do age and quality of life of patients with cancer influence quality of life of the caregiver?

M. Clark, T. Rummans, J. Sloan, 2014, Journal of geriatric oncology.

The Establishment of the GENEQOL Consortium to Investigate the Genetic Disposition of Patient-Reported Quality-of-Life Outcomes

J. Sloan, M. Sprangers, R. Veenhoven, 2009, Twin Research and Human Genetics.

TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk.

S. Cha, E. Calhoun, J. Sloan, 2003, Gynecologic oncology.

A new scoring system for predicting survival in patients with non-small cell lung cancer

J. Sloan, Ping Yang, J. Wampfler, 2015, Cancer medicine.

ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.

J. Sloan, B. Reeve, C. Cleeland, 2010, Journal of pain and symptom management.

The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study

J. Sloan, C. Cleeland, T. Mendoza, 2013, Cancer.

Assessing the Minimally Clinically Significant Difference: Scientific Considerations, Challenges and Solutions

J. Sloan, 2005, COPD.

The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.

J. Sloan, P. Novotny, Ping Yang, 2011, Journal of pain and symptom management.

Patient-reported outcomes in studies of complementary and alternative medicine: problems, solutions, and future directions.

J. Sloan, D. Eton, B. Bauer, 2011, Explore.

Assessing the clinical significance of single items relative to summated scores.

J. Sloan, N. Aaronson, D. Fairclough, 2002, Mayo Clinic proceedings.

Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey.

J. Sloan, P. Novotny, J. Bennett, 2008, Leukemia research.

Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603).

H. Cohen, J. Sloan, A. Shahrokni, 2021, JCO clinical cancer informatics.

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

J. Sloan, P. Novotny, A. Clayton, 2012, American journal of obstetrics and gynecology.

Relationship between deficits in overall quality of life and non-small-cell lung cancer survival.

M. Clark, J. Sloan, P. Novotny, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer

J. Sloan, S. Mandrekar, J. Krook, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Responsiveness and minimal important differences for patient reported outcomes

R. Hays, J. Sloan, D. Cella, 2006, Health and quality of life outcomes.

Practical Guidelines for Assessing the Clinical Significance of Health-Related Quality of Life Changes within Clinical Trials

B. Fridley, J. Sloan, T. Symonds, 2003 .

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).

P. Catalano, N. Petrelli, J. Sloan, 2019, The oncologist.

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer.

J. O'fallon, I. Heid, J. Sloan, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

UvA-DARE (Digital Academic Repository) Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes Sprangers,

J. Sloan, H. Raat, A. Barsevick, 2010 .

QLIF-08. DETERMINING THE NET CLINICAL BENEFIT IN NEURO-ONCOLOGY CLINICAL TRIALS BY COMBINING SURVIVAL AND TOXICITY DATA

J. Buckner, J. Sloan, B. Major, 2017 .

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.

Amy P Abernethy, Joseph Lipscomb, C Daniel Mullins, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians

J. Sloan, M. Mrugala, B. Fruth, 2021, Journal of Neuro-Oncology.

Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.

J. Sloan, C. Cleeland, 2010, Journal of pain and symptom management.

The problems program directors inherit: medical student distress at the time of graduation

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2011, Medical teacher.

North Central Cancer Treatment Group--achievements and perspectives.

E. Perez, J. Buckner, D. Sargent, 2008, Seminars in oncology.

Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes

J. Sloan, M. Sprangers, H. Raat, 2010, Quality of Life Research.

Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE

E. Basch, A. Bennett, J. Sloan, 2017, Clinical trials.

Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in O

J. Sloan, C. Loprinzi, E. Smith, 2019, Cancer nursing.

Development and Initial Testing of a New Socioeconomic Status Measure Based on Housing Data

B. Yawn, J. Sloan, T. Beebe, 2011, Journal of Urban Health.

Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey.

Jeff A Sloan, J. Sloan, T. Shanafelt, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials.

E. Basch, J. Sloan, A. Dueck, 2019, JAMA oncology.

Patient-reported distress and survival among patients receiving definitive radiation therapy

J. Sloan, M. Heckman, RobertI Miller, 2017, Advances in radiation oncology.

Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes.

T. Lesnick, J. Jett, J. Sloan, 2002, Lung cancer.

Conducting Cancer Control and Survivorship Research via Cooperative Groups: A Report from the American Society of Preventive Oncology

L. Minasian, J. Sloan, D. Buist, 2011, Cancer Epidemiology, Biomarkers & Prevention.

A Stoma Quality of Life Scale

J. Sloan, P. Novotny, N. Baxter, 2006, Diseases of the colon and rectum.

Quality of life after breast cancer surgery: What have we learned and where should we go next?

S. Mclaughlin, E. Perez, J. Sloan, 2009, Journal of surgical oncology.

Race, ethnicity, and medical student well-being in the United States.

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2007, Archives of internal medicine.

Interpreting and reporting results based on patient-reported outcomes.

N. Santanello, J. Sloan, D. Revicki, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Issues for Statisticians in Conducting Analyses and Translating Results for Quality of Life End Points in Clinical Trials

J. Sloan, A. Dueck, 2004, Journal of biopharmaceutical statistics.

Feasibility and Acceptability of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer.

Pamela J. McCabe, J. Sloan, A. Mansfield, 2017, Oncology nursing forum.

A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index.

J. Sloan, P. Novotny, C. Loprinzi, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Healthy immigrant families: Participatory development and baseline characteristics of a community-based physical activity and nutrition intervention.

I. Sia, M. Wieland, M. Clark, 2016, Contemporary clinical trials.

Ethnicity, Socioeconomic Status, and Health Disparities in a Mixed Rural-Urban US Community-Olmsted County, Minnesota.

J. Sloan, E. Ryu, T. Beebe, 2016, Mayo Clinic proceedings.

Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients.

J. Buckner, D. Sargent, J. Sloan, 2015, SOJ anesthesiology & pain management.

Long-Term Follow-Up and Individual Item Analysis of Quality of Life Assessments Related to Laparoscopic-Assisted Colectomy in the COST Trial 93-46-53 (INT 0146)

D. Sargent, J. Sloan, P. Novotny, 2011, Annals of Surgical Oncology.

A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults

L. Hartmann, T. Rummans, J. Sloan, 2010, Cancer Management and Research.

Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy: An NCCTG-97-24-51 Based Study

Zhifu Sun, Sumithra J Mandrekar, Ping Yang, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial.

P. Brown, M. Clark, T. Rummans, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update

J. Singh, J. Sloan, M. Sprangers, 2014, Quality of Life Research.

Treatment decision making in women newly diagnosed with breast cancer.

J. Sloan, J. Sloan, R. Owens, 1996, Cancer nursing.

Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer.

J. Sloan, P. Novotny, Ping Yang, 2011, Journal of pain and symptom management.

Applying Rasch analysis to evaluate measurement equivalence of different administration formats of the Activity Limitation scale of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)

J. Sloan, M. Gomberg-Maitland, K. Swetz, 2016, Health and Quality of Life Outcomes.

Physician Attitudes toward Palliative Care for Patients with Pulmonary Arterial Hypertension: Results of a Cross-Sectional Survey

J. Sloan, T. Shanafelt, P. Novotny, 2014, Pulmonary circulation.

Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship

M. Clark, J. Sloan, P. Novotny, 2016, Health and Quality of Life Outcomes.

Physical activity level and quality of life in long term lung cancer survivors.

C. Patten, J. Sloan, Ping Yang, 2012, Lung cancer.

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

J. Buckner, J. Singh, J. Sloan, 2014, Health and Quality of Life Outcomes.

Motivational readiness for physical activity and quality of life in long-term lung cancer survivors.

M. Clark, C. Patten, J. Sloan, 2008, Lung cancer.

Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic

Victor M Montori, Douglas L Wood, Jeff A Sloan, 2014, Patient related outcome measures.

Quality‐of‐life Measures, Clinical Significance of

J. Sloan, J. Cappelleri, Celia C. Kamath, 2006 .

Genetic variations underlying self-reported physical functioning: a review

J. Sloan, D. Patrick, M. Sprangers, 2015, Quality of Life Research.

Assessing the clinical significance of single items relative to summated scores

Joseph C. Cappelleri, Claudette Varricchio, Neil K. Aaronson, 2002 .

A two-county comparison of the HOUSES index on predicting self-rated health

B. Yawn, J. Sloan, T. Beebe, 2010, Journal of Epidemiology & Community Health.

Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers.

J. Sloan, L. Degner, L. Kristjanson, 1997, Journal of pain and symptom management.

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

J. Sloan, A. Dueck, A. Tan, 2020, Journal of Patient-Reported Outcomes.

Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer

J. Meyerhardt, D. Sargent, J. Sloan, 2005, Cancer Epidemiology Biomarkers & Prevention.

Relationship of Optimism–Pessimism and Health-Related Quality of Life in Breast Cancer Survivors

R. Colligan, M. Clark, C. Patten, 2008, Journal of psychosocial oncology.

Burnout, career satisfaction, and well-being among US neurologists in 2016

T. Cascino, J. Sloan, T. Shanafelt, 2017, Neurology.

The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression

J. Sloan, P. Erwin, M. Murad, 2017, BMC Nephrology.

Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease.

Marie E. Edwards, J. Sloan, D. Nagorney, 2020, Surgery.

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.

A. Abernethy, J. Kutner, J. Sloan, 2015, JAMA internal medicine.

Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016

T. Cascino, J. Sloan, T. Shanafelt, 2017, Neurology.

Work/Home conflict and burnout among academic internal medicine physicians.

L. Dyrbye, J. Sloan, T. Shanafelt, 2011, Archives of internal medicine.

Recommendations for including multiple symptoms as endpoints in cancer clinical trials

J. Sloan, C. Cleeland, D. Cella, 2013, Cancer.

A Prospective Study of the Relationship between Medical Knowledge and Professionalism among Internal Medicine Residents

T. Habermann, J. Kolars, J. Sloan, 2007, Academic medicine : journal of the Association of American Medical Colleges.

Parental satisfaction of U.S. physicians: associated factors and comparison with the general U.S. working population

J. Sloan, T. Shanafelt, Omar Hasan, 2016, BMC medical education.

A Double-Blinded Randomized Trial to Compare the Effectiveness of Minimally Invasive Procedures Using Patient-Reported Outcomes.

J. Sloan, P. Novotny, J. Bingener, 2015, Journal of the American College of Surgeons.

Caregiver role stress: when families become providers.

J. Sloan, P. Novotny, C. Schwartz, 2007, Cancer control : journal of the Moffitt Cancer Center.

Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).

J. Sloan, C. Loprinzi, RobertI Miller, 2009, International journal of radiation oncology, biology, physics.

Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

J. Sloan, P. Novotny, D. Cella, 2020, Journal of Patient-Reported Outcomes.

Gender Differences in Physician Service Provision Using Medicare Claims Data

M. A. Mahr, J. Sloan, T. Shanafelt, 2017, Mayo Clinic proceedings.

Qualitative and quantitative analysis of women’s perceptions of transvaginal surgery

J. Sloan, A. Mariani, J. Bingener, 2012, Surgical Endoscopy.

Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards

D. Moher, J. Sloan, H. D. de Vet, 2012, Quality of Life Research.

Measuring spiritual quality of life in patients with cancer.

P. Brown, M. Clark, T. Rummans, 2007, The journal of supportive oncology.

Quality of Life of Caregivers of Patients With Advanced-Stage Cancer

P. Brown, M. Clark, T. Rummans, 2006, The American journal of hospice & palliative care.

Will Improvement in Quality of Life (QOL) Impact Fatigue in Patients Receiving Radiation Therapy for Advanced Cancer?

P. Brown, M. Clark, T. Rummans, 2006, American journal of clinical oncology.

Prepared for what? addressing the disaster readiness gap beyond preparedness for survival

Jeff A. Sloan, J. Sloan, R. Kirk, 2015, BMC Public Health.

Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study.

N. Dreyer, J. Sloan, C. Cleeland, 2014, Breast.

Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.

M. Clark, C. Patten, J. Sloan, 2017, Clinical lung cancer.

Spiritual well-being in lung cancer survivors

M. Clark, J. Sloan, P. Novotny, 2013, Supportive Care in Cancer.

Concordance between Individual vs. Area-Level Socioeconomic Measures in an Urban Setting

J. Sloan, T. Beebe, Y. Juhn, 2015, Journal of health care for the poor and underserved.

Analysis and interpretation of results based on patient-reported outcomes.

N. Santanello, J. Sloan, D. Revicki, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

J. Sloan, J. Singh, 2008, Rheumatology.

Spirituality and Emotional Distress Among Lung Cancer Survivors.

M. Clark, C. Patten, J. Sloan, 2019, Clinical lung cancer.

Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance).

J. Sloan, C. Loprinzi, L. Shuster, 2014 .

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

M. Clark, T. Rummans, J. Sloan, 2013, Supportive Care in Cancer.

Application of therapeutic harp sounds for quality of life among hospitalized patients.

J. Sloan, P. Novotny, D. M. Schneider, 2015, Journal of pain and symptom management.

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)

H. Cohen, E. Winer, C. Hudis, 2017, Breast Cancer Research and Treatment.

Is it simple or simplistic?

G. Norman, J. Sloan, KathleenW. Wyrwich, 2003, Medical care.

Overall survival and self-reported fatigue in patients with esophageal cancer

J. Sloan, A. Jatoi, Y. Romero, 2013, Supportive Care in Cancer.

QOL SOS: Quality of Life State of the Science

J. Sloan, 2005 .

QOL SOS : Quality of life state of the science: An editorial series

J. Sloan, 2005 .

Age and sex differences in burnout, career satisfaction, and well-being in US neurologists

T. Cascino, J. Sloan, T. Shanafelt, 2018, Neurology.

Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies.

J. Sloan, I. Hassan, Robert C Cima, 2006, Gastroenterology clinics of North America.

A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials

J. Buckner, J. Sloan, P. Novotny, 2008 .

A nurse practitioner directed intervention improves the quality of life of patients with metastatic cancer: results of a randomized pilot study.

J. Sloan, M. Lesperance, S. Dyar, 2012, Journal of palliative medicine.

Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks

J. Sloan, P. Novotny, D. Cella, 2022, Quality of Life Research.

Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

L. Minasian, J. Sloan, B. Reeve, 2012 .

Caregivers of Patients With Cancer Fatigue

P. Brown, M. Clark, T. Rummans, 2014, The American journal of hospice & palliative care.

Development and Validation of a Disease‐Specific Questionnaire to Assess Patient‐Reported Symptoms in Polycystic Liver Disease

Marie E. Edwards, J. Sloan, P. Kamath, 2016, Hepatology.

Genetic variations and patient-reported quality of life among patients with lung cancer.

M. Clark, J. Sloan, Ping Yang, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proceedings of Patient Reported Outcome Measures (PROMs) Conference Birmingham 2018

Kathy, Mogens, Collette, 2018, Journal of Patient-Reported Outcomes.

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

L. Collette, M. Piccart, M. Taphoorn, 2018, Clinical trials.

Application of a novel socioeconomic measure using individual housing data in asthma research: an exploratory study

B. Yawn, J. Sloan, T. Beebe, 2014, npj Primary Care Respiratory Medicine.

A Pessimistic Explanatory Style Is Prognostic for Poor Lung Cancer Survival

R. Colligan, M. Clark, D. Szydlo, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Rising importance of patient-reported outcomes.

Jeff A Sloan, J. Sloan, Pamela J Atherton, 2006, The Lancet. Oncology.

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.

J. Sloan, R. Goldberg, A. Adjei, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers.

M. Clark, T. Rummans, J. Sloan, 2015, Journal of pain and symptom management.

Genetics and the quality of life.

J. Sloan, Xinghua Zhao, 2006, Study encounter.

Genetic Influences on Quality of Life

J. Sloan, M. Thong, J. Ordoñana, 2021, Encyclopedia of Quality of Life and Well-Being Research.

Genetic disposition of quality of life

J. Sloan, M. Sprangers, A. Michalos, 2014 .

Metrics to assess quality of life after management of early-stage lung cancer.

J. Sloan, 2011, Cancer journal.

Development of novel emoji scale to measure patient-reported outcomes in cancer patients.

J. Sloan, P. Novotny, K. Yost, 2018 .

Cancer caregiver quality of life: need for targeted intervention

M. Clark, T. Rummans, J. Sloan, 2016, Psycho-oncology.

A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot

D. Sargent, J. Sloan, J. Laurie, 2002, Quality of Life Research.

Is the use of QOL data really any different than other medical testing?

J. Sloan, A. Dueck, M. Halyard, 2006, Current problems in cancer.

Complementary and alternative medicine use among long‐term lymphoma survivors: A pilot study

Matthew M Clark, Brent A Bauer, Jeff A Sloan, 2009, American journal of hematology.

Quality-of-life meta-analysis: why treat it differently?

J. Sloan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life III: translating the science of quality-of-life assessment into clinical practice-an example-driven approach for practicing clinicians and clinical researchers.

David Cella, Gordon Guyatt, Jeff A Sloan, 2003, Clinical therapeutics.

Quality of Life endpoints in prostate chemoprevention trials.

J. Sloan, C. Varricchio, 2001, Urology.

The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).

C. Gotay, J. Sloan, C. Moinpour, 2015, Journal of pain and symptom management.

Genetics and quality of life.

J. Sloan, Cathy Zhao, 2006, Current problems in cancer.

Stoma location and ostomy-related quality of life among cancer survivors with ostomies: A pooled analysis.

J. Sloan, M. Hornbrook, S. Malkowicz, 2021, American journal of surgery.

Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.

M. Clark, J. Singh, T. Rummans, 2010, The American journal of managed care.

The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes.

J. Sloan, A. Dueck, M. Rothman, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL).

D. Sargent, J. Sloan, H. McLeod, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Spiritual quality of life in advanced cancer patients receiving radiation therapy

M. Clark, T. Rummans, J. Sloan, 2014, Psycho-oncology.

PROMIS for Laparoscopy

J. Sloan, D. Farley, J. Bingener, 2015, Journal of Gastrointestinal Surgery.

Responsiveness of quality of life instruments for the comparison of minimally invasive cholecystectomy procedures

J. Sloan, J. Bingener, L. S. Ghahfarokhi, 2013, Surgical Endoscopy.

Training Mid-level Providers on Palliative Care

J. Sloan, E. Dunbar, M. Lesperance, 2013, The American journal of hospice & palliative care.

Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant.

J. Sloan, A. Tan, V. Roy, 2019, Hematology/oncology and stem cell therapy.

Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).

E. Perez, W. McCaskill-Stevens, J. Sloan, 2014 .

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

H. Cohen, D. Berry, E. Winer, 2016, Breast Cancer Research and Treatment.

Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness.

A. Abernethy, J. Kutner, J. Sloan, 2017, Journal of palliative medicine.

Patient-reported outcomes (PRO) in patients with metastatic breast cancer (MBC) from the VIRGO observational cohort study (OCS).

N. Dreyer, J. Sloan, C. Cleeland, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2367 : Does Zinc Sulfate To Prevent Radiation-Induced Taste Alterations (“Dysgeusia”) in Head and Neck Cancer Patients? A North Central Cancer Treatment Group (NCCTG) Placebo-Controlled Trial (N01C4)

J. Sloan, C. Loprinzi, J. Kugler, 2006 .

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales.

J. Buckner, J. Singh, J. Sloan, 2014 .

Measuring outcomes in randomized prospective trials in palliative care.

J. Sloan, D. Cella, A. Dueck, 2007, Journal of pain and symptom management.

Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty

J. Singh, J. Sloan, 2009, Clinical Rheumatology.

Intellectual Equipoise and Challenges: Accruing Patients With Advanced Cancer to a Trial Randomizing to Surgical or Nonsurgical Management (SWOG S1316)

S. Hendren, G. Anderson, J. Sloan, 2020, The American journal of hospice & palliative care.

Characteristics of long-term lung cancer survivors.

M. Clark, J. Sloan, J. Cunningham, 2006 .

Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data.

Vojtech Huser, Charles Mayo, Todd McNutt, 2016, International journal of radiation oncology, biology, physics.

Complementary and alternative medicine (CAM) use by patients enrolled in phase I clinical trials

J. Sloan, S. Mandrekar, A. Adjei, 2004 .

Prospective longitudinal cohort study of patient recovery after major gastrointestinal surgery: is there a difference between minimally invasive and open approaches?

J. Sloan, P. Novotny, J. Bingener, 2019, Surgical Endoscopy.

Burnout and Quality of Life among Healthcare Research Faculty.

L. Dyrbye, J. Sloan, T. Shanafelt, 2015 .

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD

J. Buckner, D. Petereit, E. Basch, 2018, BMC Cancer.

Six-month quality-of-life and functional status of acute respiratory distress syndrome survivors compared to patients at risk: a population-based study

J. Sloan, M. Malinchoc, O. Gajic, 2015, Critical Care.

Impact of Massage Therapy on the Quality of Life of Hospice Patients and Their Caregivers: A Pilot Study

J. Sloan, B. Bauer, J. Strand, 2020, Journal of Palliative Care.

Quality of life in hospice patients. A pilot study.

T. Rummans, J. Sloan, J. Sloan, 1999, Psychosomatics.

Medical Student Burnout and Professionalism—Reply

L. Dyrbye, J. Sloan, T. Shanafelt, 2011 .

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.

T. Sellers, D. Schaid, S. McDonnell, 2000, JAMA.

Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards Michael BrundageJane BlazebyDennis RevickiBrenda BassHenrica de Vet • Helen DuffyFabio EfficaceMadeleine KingCindy L. K. LamDavid Moher • Jane ScottJeff SloanClaire SnyderSusan YountMelanie Calvert

D. Moher, J. Sloan, Jane A. Scott, 2013 .

Towards the prevention of acute lung injury: a population based cohort study protocol

J. Sloan, M. Malinchoc, O. Gajic, 2010, BMC emergency medicine.

Author response: Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016

T. Cascino, J. Sloan, T. Shanafelt, 2018, Neurology.

Overview and Introduction

J. Sloan, 2005 .

Patient-reported outcomes, emoji, and activity measured on the Apple Watch in cancer patients.

Kathryn J. Ruddy, Jeff A Sloan, Carrie A. Thompson, 2018 .

Practical and philosophical issues surrounding a national item bank: if we build it will they come?

J. Sloan, D. Revicki, 2007, Quality of Life Research.

Physical activity level and quality of life in long term lung cancer survivors.

C. Patten, J. Sloan, Ping Yang, 2012, Lung cancer.

Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer

J. Meyerhardt, D. Sargent, J. Sloan, 2005, Cancer Epidemiology Biomarkers & Prevention.

Burnout and satisfaction with work-life balance among US physicians relative to the general US population.

J. Sloan, T. Shanafelt, C. West, 2012, Archives of internal medicine.

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

J. Sloan, P. Novotny, A. Clayton, 2012, American journal of obstetrics and gynecology.

Factors associated with resilience to and recovery from burnout: a prospective, multi‐institutional study of US medical students

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2010, Medical education.

Efficacy of a Brief Screening Tool to Identify Medical Students in Distress

L. Dyrbye, D. Szydlo, J. Sloan, 2011, Academic medicine : journal of the Association of American Medical Colleges.

University of Birmingham Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

L. Collette, M. Piccart, M. Taphoorn, 2018 .

Maltese Perspectives on Breaking Bad News in Cancer: An Assessment of Patients’ Preferences

J. Sloan, P. Parker, J. Azzopardi, 2022, Ethical Challenges for Healthcare Practices at the End of Life: Interdisciplinary Perspectives.

Breaking Bad News in Cancer

J. Sloan, P. Parker, J. Azzopardi, 2017 .

A Case Management System for Integrating Patient-reported Outcome Assessment in Clinical Practice: The Beacon Tool

J. Sloan, D. Zahrieh, A. Tan, 2019, Medical care.

Health and Quality of Life Outcomes

R. Hays, J. Sloan, D. Cella, 2006 .

Relationship between work-home conflicts and burnout among American surgeons: a comparison by sex.

J. Freischlag, L. Dyrbye, J. Sloan, 2011, Archives of surgery.

Expanding beyond maximum grade: Chemotherapy toxicity over time by age and performance status in advanced non-small cell lung cancer in CALGB 9730 (Alliance A151729).

H. Cohen, W. Wood, J. Sloan, 2020, The oncologist.

J. Sloan, D. Eton, V. Montori, 2022 .

Validation of single item Linear Analogue Scale Assessments (LASAs) for assessing quality of life (QOL) in patients with newly diagnosed high-grade gliomas.

J. Buckner, P. Brown, M. Clark, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of a staging system for chemotherapy‐induced stomatitis: Western Consortium for Cancer Nursing Research

J. Sloan, L. Degner, N. Stewart, 1991, Cancer nursing.

Longitudinal Study Evaluating the Association Between Physician Burnout and Changes in Professional Work Effort.

S. Swensen, J. Sloan, T. Shanafelt, 2016, Mayo Clinic proceedings.

The problems program directors inherit: medical student distress at the time of graduation

William V. Harper, Matthew R. Thomas, L. Dyrbye, 2011, Medical teacher.

Effect of 24-hour mandatory vs on-demand critical care specialist presence on long-term survival and quality of life of critically ill patients in the intensive care unit of a teaching hospital.

J. Sloan, M. Malinchoc, O. Gajic, 2012, Journal of critical care.

Palliative care consultations in patients with cancer: a mayo clinic 5-year review.

J. Sloan, E. Carey, T. Moynihan, 2011, Journal of oncology practice.

Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.

M. Bertagnolli, E. Basch, A. Bennett, 2020 .

Feasibility and Acceptability of a Dignity Therapy/Life Plan Intervention for Patients With Advanced Cancer.

Pamela J. McCabe, J. Sloan, A. Mansfield, 2017, Oncology nursing forum.

Outcomes Assessment in Cancer: Statistical issues in the application of cancer outcome measures

J. Sloan, 2004 .

Avoiding Burnout: The Personal Health Habits and Wellness Practices of US Surgeons

J. Sloan, T. Shanafelt, C. Balch, 2012, Annals of surgery.

Ability of the physician well-being index to identify residents in distress.

L. Dyrbye, J. Sloan, T. Shanafelt, 2014, Journal of graduate medical education.

Stoma location and ostomy-related quality of life among cancer survivors with ostomies: A pooled analysis.

J. Sloan, M. Hornbrook, S. Malkowicz, 2021, American journal of surgery.